The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers

Míreanna comhchosúla

• Detection of Thiopurine S-Methyltransferase (TPMT) Polymorphisms TPMT*3A, TPMT*3B and TPMT*3C in Children with Acute Lymphoblastic Leukemia
  de réir: Nawar S. Mohammed, et al.
  Foilsithe / Cruthaithe: (2018-12-01)
• Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
  de réir: Mehdi Azad, et al.
  Foilsithe / Cruthaithe: (2009-01-01)
• Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
  de réir: Lennard, L, et al.
  Foilsithe / Cruthaithe: (2013)
• Thiopurine methyltransferase (TPMT), nudix hydrolase 15 (NUDT-15) and methylene tetrahydrofolate reductase (MTHFR)polymorphisms in children with acute lymphoblastic leukaemia
  de réir: Srikanth Marda, et al.
  Foilsithe / Cruthaithe: (2022-01-01)
• Positive TPMT genotype-phenotype correlation underscores importance of TPMT genotyping for personalized thiopurine dosing
  de réir: Hui-min, Neoh, et al.
  Foilsithe / Cruthaithe: (2012)